10-K: 3D Systems Reports FY2024 Results: Revenue Declines, Strategic Divestiture Announced
Annual Results
3D Systems' FY2024 results reveal a revenue decrease alongside a strategic decision to divest its Geomagic software business.
Summary
- 3D Systems reported a decrease in revenue for the year ended December 31, 2024, totaling $440.1 million compared to $488.1 million in 2023.
- The company experienced a net loss attributable to 3D Systems Corporation of $255.6 million in 2024, compared to a net loss of $362.7 million in 2023.
- Product revenue decreased by 15.1%, while services revenue increased by 1.0% year-over-year.
- Gross profit decreased by 16.4% to $164.2 million, with a gross profit margin of 37.3% in 2024.
- The company recorded asset impairment charges of $145.0 million in 2024, down from $302.8 million in 2023.
- 3D Systems is divesting its Geomagic software business to Hexagon AB for $123 million, expected to close by the end of Q2 2025.
- The company is implementing a 2025 Restructuring Plan to streamline operations and improve profitability, expecting significant annual savings starting in H1 2025.
- The company had $171.3 million in cash and cash equivalents as of December 31, 2024, a decrease of $160.2 million from the previous year.
- The company is addressing material weaknesses in internal control over financial reporting.
- The company is no longer eligible to use a Form S-3 registration statement, which could impair capital-raising activities.
Sentiment
Score: 4
Explanation: The document presents a mixed picture. While the net loss improved, revenue declined, and cash reserves decreased. The restructuring plan and divestiture offer potential for future improvement, but material weaknesses in internal control and ineligibility for Form S-3 raise concerns.
Positives
- The net loss improved year-over-year, indicating progress in managing expenses.
- Asset impairment charges decreased significantly, suggesting a more stable asset base.
- The divestiture of Geomagic will provide additional capital.
- The 2025 Restructuring Plan aims to improve profitability and streamline operations.
- The company is addressing material weaknesses in internal control over financial reporting.
Negatives
- Revenue decreased by 9.8% in FY2024, indicating challenges in sales growth.
- The company continues to report a net loss.
- Cash and cash equivalents decreased significantly, raising concerns about liquidity.
- The company identified material weaknesses in internal control over financial reporting.
- The company is no longer eligible to use a Form S-3 registration statement.
Risks
- Current macro-economic trends and geopolitical landscape could continue to adversely affect the business.
- The loss of, continued reduction or substantial decline in revenue from larger clients could have a material adverse effect on revenues, profitability and liquidity.
- Changes in business conditions may cause goodwill, intangible assets, long-lived tangible assets, or right-of-use assets to become impaired.
- The company's uneven sales cycle makes planning and inventory management difficult and future financial results less predictable.
- The company's products and services may experience quality problems from time to time that can result in decreased sales and operating margin, product returns, product liability, and warranty or other claims that could result in significant expenses and harm to our reputation.
- The company depends on external vendors and suppliers for the components and spare parts for its 3D printers and for chemicals and packaging used in its materials.
- The company is subject to environmental, health and safety laws and regulations related to its operations and the use of its systems and materials, including requirements imposed due to use of its products by its customers, which could subject it to compliance costs and/or potential liability in the event of non-compliance.
- If the company does not generate net cash flow from operations and if it is unable to raise additional capital, its financial condition could be adversely affected and it may not be able to execute its business strategy.
- The company's business could be adversely impacted in the event of a failure of its information technology infrastructure or a successful cyber-attack.
- The company is subject to numerous laws, regulations, and contractual obligations designed to protect its regulated data, and that of its customers.
- Servicing or refinancing the company's debt may require a significant amount of cash, and the company may not have sufficient cash or the ability to raise the funds necessary to settle conversions of the 0% convertible senior notes due 2026 in cash, repay the notes at maturity, or repurchase the notes as required following a fundamental change.
- The company's operations and business performance could suffer if it is unable to attract and retain senior management or other key employees.
- The company has made, and may make in the future, strategic acquisitions and divestitures that may involve significant risks and uncertainties.
- The company believes that its future success depends on its ability to deliver products and services that meet changing technology and customer needs.
- The success of the company's regenerative medicine efforts depends on developing and commercializing products, either ourselves or in conjunction with development partners, that are subject to technical and market risks.
- The company is subject to U.S. and other anti-corruption laws, trade controls, economic sanctions, privacy regulations, and other similar laws and regulations.
- The company is subject to complex government laws and regulations relating to certain product sets and failure to meet the stringent requirements could impact its business operations and financial position.
- Failure to comply with the terms of the company's settlement agreements with the U.S. Departments of State, Commerce, and Justice could have a material and adverse impact on its business, results of operations and financial condition, and, even if it complies with those settlement agreements, the costs and burdens of compliance could be significant, and it may face additional investigations and proceedings from other governmental entities or third parties related to the same or similar conduct underlying the agreements.
- As a result of the delayed filing of the company's 2023 Form 10-K, its Form 10-Q for the quarter ended March 31, 2024, its Form 10-Q for the quarter ended June 30, 2024, and its Form 10-Q for the quarter ended September 30, 2024, the Company has experienced risks and costs and expects to experience additional risks and costs in the future, including with respect to the SEC's ongoing investigation.
- The company is no longer eligible to use a Form S-3 registration statement, which could impair its capital-raising activities.
- The company derives a significant portion of its revenue from business conducted outside the U.S. and are subject to the risks of doing business outside the U.S.
- The company may incur substantial costs enforcing or acquiring intellectual property rights and defending against third-party claims as a result of litigation or other proceedings.
- The company may not be able to protect its intellectual property rights and confidential information, including its digital content, from third-party infringers or unauthorized copying, use or disclosure.
- Changes in, or interpretation of, tax rules and regulations may impact the company's effective tax rate and future profitability.
- Material weaknesses in the company's internal control over financial reporting could result in material misstatements in its financial statements not being prevented or detected, which could affect investor confidence in the accuracy and completeness of its financial statements and could negatively impact its stock price and financial condition.
Future Outlook
The company expects to realize significant annual savings from the 2025 Restructuring Plan starting in the first half of 2025. The company believes that it has the financial resources needed to meet its cash requirements during the next twelve months.
Industry Context
The announcement reflects the challenges and strategic shifts occurring within the 3D printing industry, as companies adapt to changing market conditions and focus on profitability.
Comparison to Industry Standards
- It is difficult to compare 3D Systems to industry standards as the document does not list any specific comparible companies, projects, and results.
- The document does not provide enough information to assess the results in the context of global benchmarks.
Legal Proceedings
- The Company is cooperating with the SEC in connection with its formal investigation, which is ongoing.
Related Party Transactions
- The Company's reported revenue and cost of sales for the year ended December 31, 2024 includes related party revenue and associated related party cost of sales of $3.8 million and $2.6 million, respectively, attributable to sales to NAMI.
- The Company's reported revenue and cost of sales for the year ended December 31, 2023 includes related party revenue and associated related party cost of sales of $1.7 million and $1.0 million, respectively, attributable to sales to NAMI.
- During December 2024, the Company entered into a short-term, non-interest bearing loan agreement with NAMI whereby NAMI borrowed $2.0 million to finance its working capital and capital expenditures requirements.
- During the years ended December 31, 2024 and December 31, 2023, the Company made purchases from Enhatch of $0.7 million and $0.2 million, respectively.
Stakeholder Impact
- Shareholders: The decrease in revenue and continued net loss may negatively impact shareholder value. The restructuring plan and divestiture could improve long-term prospects.
- Employees: The restructuring plan may result in job losses. The company is committed to creating a safe, secure, healthy, and injury-free work environment for its employees, customers, partners, and visitors.
- Customers: The divestiture of Geomagic may impact the availability of those software products. The company is focused on providing high-quality solutions and meeting evolving customer needs.
- Suppliers: The company depends on external vendors and suppliers for the components and spare parts for its 3D printers and for chemicals and packaging used in its materials.
Next Steps
- Complete the divestiture of the Geomagic software business.
- Implement and execute the 2025 Restructuring Plan.
- Remediate the identified material weaknesses in internal control over financial reporting.
- Monitor and manage cash flow to ensure sufficient liquidity.
Key Dates
| Date | Description |
|---|---|
| 2017 | 3D Systems entered into an arrangement for regenerative medicine research. |
| March 2022 | 3D Systems made a $10.0 million investment in Enhatch Inc. |
| March 2022 | 3D Systems signed an agreement to form a joint venture with Dussur. |
| December 1, 2021 | 3D Systems acquired Volumetric Biotechnologies, Inc. |
| November 16, 2021 | 3D Systems issued 0% Convertible Senior Notes due November 15, 2026. |
| July 1, 2023 | 3D Systems completed the acquisition of Wematter AB. |
| June 2023 | 3D Systems made an $8.0 million investment in Theradaptive, Inc. |
| December 2024 | 3D Systems entered into a definitive agreement for the sale of its Geomagic software business. |
| March 2025 | 3D Systems authorized the next phase of its multi-faceted cost savings and restructuring initiative (the 2025 Restructuring Plan). |
| End of Q2 2025 | Expected completion of the Geomagic divestiture. |
| November 15, 2026 | Maturity date of the 0% Convertible Senior Notes. |
Keywords
3D Systems, financial results, FY2024, revenue, net loss, restructuring, Geomagic, divestiture, impairment, internal control, Form 10-K, additive manufacturing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.